These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

459 related articles for article (PubMed ID: 21075971)

  • 21. Gender and the Sex Hormone Estradiol Affect Multiple Sclerosis Risk Gene Expression in Epstein-Barr Virus-Infected B Cells.
    Keane JT; Afrasiabi A; Schibeci SD; Fewings N; Parnell GP; Swaminathan S; Booth DR
    Front Immunol; 2021; 12():732694. PubMed ID: 34566997
    [TBL] [Abstract][Full Text] [Related]  

  • 22. EBNA1-specific T cells from patients with multiple sclerosis cross react with myelin antigens and co-produce IFN-gamma and IL-2.
    Lünemann JD; Jelcić I; Roberts S; Lutterotti A; Tackenberg B; Martin R; Münz C
    J Exp Med; 2008 Aug; 205(8):1763-73. PubMed ID: 18663124
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Trigger, pathogen, or bystander: the complex nexus linking Epstein- Barr virus and multiple sclerosis.
    Owens GP; Bennett JL
    Mult Scler; 2012 Sep; 18(9):1204-8. PubMed ID: 22685062
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A meta-analysis of interaction between Epstein-Barr virus and HLA-DRB1*1501 on risk of multiple sclerosis.
    Xiao D; Ye X; Zhang N; Ou M; Guo C; Zhang B; Liu Y; Wang M; Yang G; Jing C
    Sci Rep; 2015 Dec; 5():18083. PubMed ID: 26656273
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Epstein-Barr Virus and Multiple Sclerosis.
    Houen G; Trier NH; Frederiksen JL
    Front Immunol; 2020; 11():587078. PubMed ID: 33391262
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Immunology of multiple sclerosis.
    Pender MP; Greer JM
    Curr Allergy Asthma Rep; 2007 Jul; 7(4):285-92. PubMed ID: 17547851
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Epstein-Barr virus latent infection and BAFF expression in B cells in the multiple sclerosis brain: implications for viral persistence and intrathecal B-cell activation.
    Serafini B; Severa M; Columba-Cabezas S; Rosicarelli B; Veroni C; Chiappetta G; Magliozzi R; Reynolds R; Coccia EM; Aloisi F
    J Neuropathol Exp Neurol; 2010 Jul; 69(7):677-93. PubMed ID: 20535037
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Humoral immune response to EBV in multiple sclerosis is associated with disease activity on MRI.
    Farrell RA; Antony D; Wall GR; Clark DA; Fisniku L; Swanton J; Khaleeli Z; Schmierer K; Miller DH; Giovannoni G
    Neurology; 2009 Jul; 73(1):32-8. PubMed ID: 19458321
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dysregulated Epstein-Barr virus infection in the multiple sclerosis brain.
    Serafini B; Rosicarelli B; Franciotta D; Magliozzi R; Reynolds R; Cinque P; Andreoni L; Trivedi P; Salvetti M; Faggioni A; Aloisi F
    J Exp Med; 2007 Nov; 204(12):2899-912. PubMed ID: 17984305
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Altered EBV specific immune control in multiple sclerosis.
    Münz C
    J Neuroimmunol; 2024 May; 390():578343. PubMed ID: 38615370
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Epstein-Barr Virus and Multiple Sclerosis: A Convoluted Interaction and the Opportunity to Unravel Predictive Biomarkers.
    Ortega-Hernandez OD; Martínez-Cáceres EM; Presas-Rodríguez S; Ramo-Tello C
    Int J Mol Sci; 2023 Apr; 24(8):. PubMed ID: 37108566
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Primary Peripheral Epstein-Barr Virus Infection Can Lead to CNS Infection and Neuroinflammation in a Rabbit Model: Implications for Multiple Sclerosis Pathogenesis.
    Hassani A; Reguraman N; Shehab S; Khan G
    Front Immunol; 2021; 12():764937. PubMed ID: 34899715
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Epstein-Barr virus and multiple sclerosis: potential opportunities for immunotherapy.
    Pender MP; Burrows SR
    Clin Transl Immunology; 2014 Oct; 3(10):e27. PubMed ID: 25505955
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clonal origin of Epstein-Barr virus (EBV)-infected T/NK-cell subpopulations in EBV-positive T/NK-cell lymphoproliferative disorders of childhood.
    Ohga S; Ishimura M; Yoshimoto G; Miyamoto T; Takada H; Tanaka T; Ohshima K; Ogawa Y; Imadome K; Abe Y; Akashi K; Hara T
    J Clin Virol; 2011 May; 51(1):31-7. PubMed ID: 21377409
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Epstein-Barr virus genotypes and strains in central nervous system demyelinating disease and Epstein-Barr virus-related illnesses in Australia.
    Lay ML; Lucas RM; Toi C; Ratnamohan M; Ponsonby AL; Dwyer DE
    Intervirology; 2012; 55(5):372-9. PubMed ID: 22286116
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Epstein-Barr virus, latitude and multiple sclerosis.
    Disanto G; Pakpoor J; Morahan JM; Hall C; Meier UC; Giovannoni G; Ramagopalan SV
    Mult Scler; 2013 Mar; 19(3):362-5. PubMed ID: 22767435
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Increased frequency and broadened specificity of latent EBV nuclear antigen-1-specific T cells in multiple sclerosis.
    Lünemann JD; Edwards N; Muraro PA; Hayashi S; Cohen JI; Münz C; Martin R
    Brain; 2006 Jun; 129(Pt 6):1493-506. PubMed ID: 16569670
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Epstein-Barr virus and multiple sclerosis.
    Ascherio A; Munch M
    Epidemiology; 2000 Mar; 11(2):220-4. PubMed ID: 11021623
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Attenuated immune control of Epstein-Barr virus in humanized mice is associated with the multiple sclerosis risk factor HLA-DR15.
    Zdimerova H; Murer A; Engelmann C; Raykova A; Deng Y; Gujer C; Rühl J; McHugh D; Caduff N; Naghavian R; Pezzino G; Capaul R; Zbinden A; Ferlazzo G; Lünemann JD; Martin R; Chatterjee B; Münz C
    Eur J Immunol; 2021 Jan; 51(1):64-75. PubMed ID: 32949466
    [TBL] [Abstract][Full Text] [Related]  

  • 40. High frequency of co-infection by Epstein-Barr virus types 1 and 2 in patients with multiple sclerosis.
    Santón A; Cristóbal E; Aparicio M; Royuela A; Villar LM; Alvarez-Cermeño JC
    Mult Scler; 2011 Nov; 17(11):1295-300. PubMed ID: 21757537
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.